排卵障碍发病机制及治疗的研究进展
闫阳;方兰兰;孙莹璞;
摘要(Abstract):
排卵障碍包括稀发排卵和无排卵,是不孕症的常见病因。排卵障碍病因复杂,任何原因引起的下丘脑-垂体-卵巢轴功能异常均可导致排卵障碍。明确病因和发病机制是有效治疗排卵障碍的关键。本文重点综述了排卵障碍的WHO分型、发病机制及治疗进展,以期为排卵障碍的基础研究、临床预防及诊治提供重要的科学依据。
关键词(KeyWords): 卵泡发育;排卵障碍;下丘脑-垂体-卵巢轴
基金项目(Foundation): 国家重点研发计划(No:2019YFA0110900);; 国家自然科学基金国际(地区)合作与交流项目(No:81820108016);国家自然科学基金面上项目(No:32070848);; 河南省重点研发与推广专项(No:202102310062);; 河南省医学科技攻关项目(No:2020002052)
作者(Authors): 闫阳;方兰兰;孙莹璞;
DOI: 10.13283/j.cnki.xdfckjz.2021.06.016
参考文献(References):
- [1] Lindsay TJ,Vitrikas KR.Evaluation and treatment of infertility[J].Am Fam Physician,2015,91(5):308-314
- [2] Gordon CM,Ackerman KE,Berga SL,et al.Functional Hypothalamic Amenorrhea:An Endocrine Society Clinical Practice Guideline[J].J Clin Endocrinol Metab,2017,102(5):1413-1439
- [3] Strock NCA,De Souza MJ,Williams NI.Eating behaviours related to psychological stress are associated with functional hypothalamic amenorrhoea in exercising women[J].J Sports Sci,2020,38(21):2396-2406
- [4] Chou SH,Chamberland JP,Liu X,et al.Leptin is an effective treatment for hypothalamic amenorrhea[J].Proc Natl Acad Sci U S A,2011,108(16):6585-6590
- [5] Podfigurna A,Maciejewska-Jeske M,Meczekalski B,et al.Kisspeptin and LH pulsatility in patients with functional hypothalamic amenorrhea[J].Endocrine,2020,70(3):635-643
- [6] Dhillo WS,Chaudhri OB,Thompson EL,et al.Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women[J].J Clin Endocrinol Metab,2007,92(10):3958-3966
- [7] Navarro VM.Metabolic regulation of kisspeptin- the link between energy balance and reproduction[J].Nat Rev Endocrinol,2020,16(8):407-420
- [8] Caronia LM,Martin C,Welt CK,et al.A genetic basis for functional hypothalamic amenorrhea[J].New Engl J Med,2011,364(3):215-225
- [9] Young J,Xu C,Papadakis GE,et al.Clinical Management of Congenital Hypogonadotropic Hypogonadism[J].Endocrine Rev,2019,40(2):669-710
- [10] Cangiano B,Swee DS,Quinton R,et al.Genetics of congenital hypogonadotropic hypogonadism:peculiarities and phenotype of an oligogenic disease[J].Hum Genet,2021,140(1):77-111
- [11] Acierno JS,Xu C,Papadakis GE,et al.Pathogenic mosaic variants in congenital hypogonadotropic hypogonadism[J].Genet Med,2020,22(11):1759-1767
- [12] Neocleous V,Fanis P,Toumba M,et al.GnRH deficient patients with congenital hypogonadotropic hypogonadism:Novel Genetic Findings in ANOS1,RNF216,WDR11,FGFR1,CHD7,and POLR3A genes in a case series and review of the literature[J].Front Endocrinol,2020,11:626
- [13] Cassatella D,Howard SR,Acierno JS,et al.Congenital hypogonadotropic hypogonadism and constitutional delay of growth and puberty have distinct genetic architectures[J].Eur J Endocrinol,2018,178(4):377-388
- [14] Kim SH.Congenital Hypogonadotropic hypogonadism and kallmann syndrome:past,present,and future[J].Endocrinol Metab (Seoul),2015,30(4):456-466
- [15] Amato LGL,Montenegro LR,Lerario AM,et al.New genetic findings in a large cohort of congenital hypogonadotropic hypogonadism[J].Eur J Endocrinol,2019,181(2):103-119
- [16] Matsuzaki S,Endo M,Ueda Y,et al.A case of acute Sheehan's syndrome and literature review:a rare but life-threatening complication of postpartum hemorrhage[J].BMC Pregn Childbirth,2017,17(1):188
- [17] Ruan X,Li M,Mueck AO.Why does polycystic ovary syndrome (PCOS) need long-term management?[J].Curr Pharm Des,2018,24(39):4685-4692
- [18] Chen Y,Fang SY.Potential genetic polymorphisms predicting polycystic ovary syndrome[J].Endocrine Connect,2018,7(5):R187-R195
- [19] Manna PR,Stetson CL,Slominski AT,et al.Role of the steroidogenic acute regulatory protein in health and disease[J].Endocrine,2016,51(1):7-21
- [20] Mykhalchenko K,Lizneva D,Trofimova T,et al.Genetics of polycystic ovary syndrome[J].Expert Rev Mol Diagn,2017,17(7):723-733
- [21] Li T,Mo H,Chen W,et al.Role of the PI3K-Akt Signaling Pathway in the Pathogenesis of Polycystic Ovary Syndrome[J].Reprod Sci (Thousand Oaks,Calif),2017,24(5):646-655
- [22] Vilar L,Vilar CF,Lyra R,et al.Pitfalls in the diagnostic evaluation of hyperprolactinemia[J].Neuroendocrinol,2019,109(1):7-19
- [23] Bidet M,Bachelot A,Bissauge E,et al.Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure[J].J Clin Endocrinol Metab,2011,96(12):3864-3872
- [24] 陈子江,孙贇.早发性卵巢功能不全的遗传因素[J].中国实用妇科与产科杂志,2021,37(1):7-12
- [25] Qin Y,Jiao X,Simpson JL,et al.Genetics of primary ovarian insufficiency:new developments and opportunities[J].Hum Reprod Update,2015,21(6):787-808
- [26] Thanatsis N,Kaponis A,Koika V,et al.Reduced Foxo3a,FoxL2,and p27 mRNA expression in human ovarian tissue in premature ovarian insufficiency[J].Hormones (Athens),2019,18(4):409-415
- [27] Shen H,Wang Y.Activation of TGF-beta1/Smad3 signaling pathway inhibits the development of ovarian follicle in polycystic ovary syndrome by promoting apoptosis of granulosa cells[J].J Cell Physiol,2019,234(7):11976-11985
- [28] 朱静,杨庆岭,孙莹璞.mTOR与卵泡发育[J].国际生殖健康/计划生育杂志,2019,38(2):150-153
- [29] Qiao GY,Dong BW,Zhu CJ,et al.Deregulation of WNT2/FZD3/beta-catenin pathway compromises the estrogen synthesis in cumulus cells from patients with polycystic ovary syndrome[J].Biochem Biophys Res Commun,2017,493(1):847-854
- [30] Gustin SE,Hogg K,Stringer JM,et al.WNT/β-catenin and p27/FOXL2 differentially regulate supporting cell proliferation in the developing ovary[J].Devel Biol,2016,412(2):250-260
- [31] Atabiekov I,Hobeika E,Sheikh U,et al.The role of gene therapy in premature ovarian insufficiency management[J].Biomedicines,2018,6(4):102
- [32] Flageole C,Toufaily C,Bernard DJ,et al.Successful in vitro maturation of oocytes in a woman with gonadotropin-resistant ovary syndrome associated with a novel combination of FSH receptor gene variants:a case report[J].J Assisted Reprod Genet,2019,36(3):425-432
- [33] Zhang Y,Yan Z,Qin Q,et al.Transcriptome Landscape of Human Folliculogenesis Reveals Oocyte and Granulosa Cell Interactions[J].Mol Cell,2018,72(6):1021-1034.e4
- [34] 牟珍妮,孙振高,宋景艳,等.卵巢不敏感综合征发病机制及管理策略的研究进展[J].现代妇产科进展,2018,27(3):232-234
- [35] Smyka M,Grzechocinska B,Wielgos M.The role of lifestyle changes in the treatment of polycystic ovary syndrome[J].Neuro Endocrinol Lett,2018,38(8):521-527
- [36] Malina A,Biaszkiewicz A,Owczarz U.Psychosocial aspects of infertility and its treatment[J].Ginekol Polska,2016,87(7):527-531
- [37] Haemmerli Keller K,Alder G,Loewer L,et al.Treatment-related psychological stress in different in vitro fertilization therapies with and without gonadotropin stimulation[J].Acta Obstet Gynecol Scand,2018,97(3):269-276
- [38] Frederiksen Y,Farver-Vestergaard I,Skovgard NG,et al.Efficacy of psychosocial interventions for psychological and pregnancy outcomes in infertile women and men:a systematic review and meta-analysis[J].BMJ Open,2015,5(1):e006592
- [39] Mumford SL,Johnstone E,Kim K,et al.A Prospective Cohort Study to Evaluate the Impact of Diet,Exercise,and Lifestyle on Fertility:Design and Baseline Characteristics[J].Am J Epidemiol,2020,189(11):1254-1265
- [40] Son WY,Henderson S,Cohen Y,et al.Immature oocyte for fertility preservation[J].Front Endocrinol,2019,10:464
- [41] Mohsenzadeh M,Salehi-Abargouei A,Tabibnejad N,et al.Effect of vitrification on human oocyte maturation rate during in vitro maturation procedure:A systematic review and meta-analysis[J].Cryobiol,2018,83:84-89
- [42] Siristatidis CS,Maheshwari A,Vaidakis D,et al.In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction[J].Cochrane Database Syst Rev,2018,11(11):CD006606
- [43] 孙文枫,苏迎春,孙莹璞.人卵巢组织冷冻保存及应用研究进展[J].国际生殖健康/计划生育杂志,2009,28(3):151-154
- [44] 吴霜.mTOR信号通路激活剂MHY1485应用于人卵巢组织体外激活的有效性及安全性研究[D].上海:中国人民解放军海军军医大学,2018
- [45] Gellert SE,Pors SE,Kristensen SG,et al.Transplantation of frozen-thawed ovarian tissue:an update on worldwide activity published in peer-reviewed papers and on the Danish cohort[J].J Assist Reprod Genet,2018,35(4):561-570
- [46] 高明霞,张学红,孙航.卵巢组织体外培养及冻融技术的研究进展[J].中华生殖与避孕杂志,2018,38(10):817-820